Search

everythinglearnresearchcommunity

for

Search:↓

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

People with a family history of hair loss are more likely to experience it, and the severity of hair loss is linked to insulin resistance. The connection between early hair loss and oxidative stress needs more investigation.

Alopecia areata patients may have higher blood pressure and blood sugar, indicating a future risk of metabolic issues.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

PCOS treatment should address both symptoms and metabolic risks, starting with lifestyle changes and possibly including medication.

Skin symptoms can indicate endocrine disorders and have various treatments.

Treating ovarian-related inflammation may help hair regrowth in women with alopecia areata.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.